Top Tech Companies in Boston, MA (4,377)

Profitability: Operating income has risen materially alongside growth, with the latest quarter reporting meaningful GAAP and adjusted operating profits and expanding margins. This indicates the business is scaling while improving earnings quality.

Resilient & Sustainable Growth: Gross profit is expanding at a strong, accelerating pace, with both Cash App and Square contributing and management raising full‑year outlooks. Longer‑term disclosures also highlight multi‑year compounding in gross profit per user across ecosystems.

Cost & Operational Efficiency: A leaner organizational structure and disciplined spending have driven record adjusted operating margins and improved operating leverage. Efficiency gains appear to be a second engine alongside revenue drivers.

Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.

Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.

Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.

Strong Revenue Growth: Recent results show accelerating top-line momentum, with FY2025 up 28% and Q2 2026 revenue up 36% year over year after 32% in Q1. Management also raised 2026 revenue guidance to $4.45B–$4.47B, indicating confidence in continued expansion.

Healthy Cash Flow: Cash generation is substantial, including Q2 2026 operating cash flow of $316M and free cash flow of $279M with about a 25% free-cash-flow margin. The company also reported roughly $5.0B in cash, cash equivalents and marketable securities as of June 30, 2026.

Customer Loyalty & Retention: Expansion within the installed base is a key driver, with about 75% of the 2025 revenue increase coming from existing customers and rising multi‑product adoption. Larger accounts are also expanding, as $100K+ ARR customers grew roughly 23% year over year to ~4,720 in Q2 2026.

Strong Revenue Growth: Revenue is rising at a double-digit pace, with FY2025 up about 32% to $1.234B and Q1–Q2 2026 growing roughly 28% and 26% year over year, alongside raised FY2026 guidance implying around 24% growth. Larger-account cohorts also expanded materially, reinforcing the top-line trajectory.

Customer Loyalty & Retention: Dollar-based net revenue retention was approximately 109–110%, indicating existing customers are expanding spend on the platform. Higher-value segments grew quickly as well, including customers generating over $50K in ARR rising in the mid-to-high 30% range year over year.

Market Expansion: International revenue is outpacing overall growth, including 42% growth in FY2025 and mid-30% growth in early 2026. Total customers also surpassed 205,000 globally as enterprise and multi-product adoption broadened.

Strong Revenue Growth: Revenue increased 19% in 2025 and accelerated in 2026 with 22% year-over-year growth in Q1 and 27% in Q2, while first-half 2026 revenue rose 25% year over year. Management raised full-year 2026 guidance to $94–96M, implying roughly 22–24% growth.

Customer Loyalty & Retention: Net Dollar Retention reached 117% in Q1 2026, indicating expanding spend from existing accounts after churn. Core genomics customers rose to 537 as of March 31, 2026, with record new customer additions in 2025.

Market Expansion: Geographic momentum is evident with Q1 2026 analysis volume up 28% in the U.S. and 31% in APAC, and EMEA revenue up 30%. Platform usage set records (e.g., 108,000 analyses in Q1 and 115,000 in Q2), with liquid biopsy volumes growing sharply.

Profitability: Square gross profit increased year over year in 2025 and again in recent quarters, with gains driven by processing, software, and financial solutions like Square Loans. Filings indicate this momentum continued into 2026, with growth excluding hardware also improving.

Strong Market Position & Advantage: Square is described as a leader in small-business POS and commerce, serving millions of sellers and processing a very large volume of payments. Industry recognition and scale suggest durable competitive positioning in its core segments.

Market Expansion: International payment volume is growing faster than the U.S., and sectors such as food and beverage led recent gains. Seller acquisition accelerated late in 2025, indicating widening reach across geographies and customer segments.

Strong Revenue Growth: Recent results indicate FY2026 revenue rose 19% year over year to roughly $2.02B, with Q1 FY2027 revenue up 16% and ARR up 17%. This points to steady double‑digit expansion across both total and recurring revenue.

Customer Loyalty & Retention: Dollar-based net retention is reported around 110–111%, and ARR growth has tracked slightly ahead of revenue growth. These signals suggest existing customers are expanding usage alongside new logo additions.

Healthy Cash Flow: Company materials highlight strong free cash flow alongside growth, including substantial FY2026 free cash flow and robust margins in recent quarters. The business has also returned capital via notable share repurchases.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.

Investor Backing & Capital Strength: Fresh equity and repeat securitizations are expanding financing capacity, including a $50M raise in December 2025 and multiple HEI securitizations culminating in a $300M deal in 2025. These transactions provide recycled capital to originate more home equity investments.

Strong Market Position & Advantage: Independent and company disclosures place Hometap among a small cohort leading HEIs, with more than $2B deployed and 20,000–24,000+ homeowners served. Prominent coverage and regulatory overviews consistently cite the firm alongside top peers in this niche.

Market Expansion: Geographic reach and customer count advanced through 2025–2026, with offerings rolled out to additional states and homeowners served progressing from 20,000+ to 24,000+. Company outlook materials frame 2026 as a period of “disciplined expansion,” aligning with continued footprint growth.

Strong Revenue Growth: Company statements indicate a compound growth rate above 35% over four years, with the U.S. business more than doubling over two years. One industry dataset also estimates revenue rising from roughly $28.6M in 2023 to about $53.2M in 2024, suggesting strong top-line momentum.

Market Expansion: Customer counts are described as progressing from 600+ (2022) to 850+ (2023) and 900+ enterprise customers more recently, alongside more than 100% growth in the U.S. over two years. The footprint spans multiple countries with offices in Europe, the U.S., and Australia, pointing to ongoing international scaling.

Investor Backing & Capital Strength: Capital support is evidenced by a $135M Series D in 2022 and approximately $196M raised overall. The company also pursued tuck-in acquisitions such as Unifai and PricingHUB, consistent with a well-funded expansion strategy.

Investor Backing & Capital Strength: Funding progressed from a 2022 seed to a 2023 Series A and a $27M Series B in 2025, led by established firms, indicating strong capital support. Independent listings also note roughly $44M+ raised to date.

Market Expansion: The customer base expanded from 1,000+ paying businesses in 2022 to 6,000+ across all 50 states by 2025–2026, signaling broader penetration. Reported booked business rose from $25M+ (2022) to $655M+ (2025) and $1.2B+ (2026), reflecting sharply higher platform activity.

Product Line Growth: Offerings evolved from AI-generated websites to a broader suite spanning marketing, bookings, payments, CRM/messaging, and an AI 'Sidekick' mobile app. This widening scope is accompanied by continued hiring across sales, product, engineering, and AI/ML to support scale.

Strong Revenue Growth: Revenue growth is underscored by consecutive placements on Deloitte Technology Fast 500 and the Inc. 5000, indicating multi-year expansion measured through 2025. Recognition spans overlapping earlier periods and a more recent measurement window, signaling sustained momentum rather than a one-off spike.

Market Expansion: Geographic reach widened with the opening of a UK office to support customers in the UK and EMEA following the international-payments launch and 2025 rebrand. This move complements a global customer base reported in prior updates.

Product Line Growth: The platform broadened with launches such as International Payments and Touchless Invoice Processing, with further plans cited for e-invoicing, analytics, and faster payment processing. Rising invoice-processing volumes over 2023–2025 further reflect growing adoption.

Strong Hiring & Retention: Headcount is described as rising from about 134 in 2023 to roughly 176 by March 2026, and job postings increased from 2024 into 2026, pointing to active hiring. This trend indicates added capacity to support continued expansion.

Strategic Partnerships: A global partnership model announced in 2024 brought other freelance marketplaces into the network, signaling deliberate ecosystem expansion. These partnerships support broader geographic reach and customer access.

Strong Market Position & Advantage: The company highlights a substantial enterprise footprint, including a significant share of Fortune 500 companies, reflecting deep penetration at the high end of the market. It was also named the 2nd fastest‑growing company in Massachusetts based on three‑year revenue growth, reinforcing competitive standing.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Investor Backing & Capital Strength: Capital raising has accelerated, including a $372M Series D in 2024 with total funding reported in the hundreds of millions to expand the pipeline and AI platform. Valuation has stepped up from roughly $1.04B (2021) to about $1.48B post‑money (2024), signaling strengthened private‑market positioning.

Strategic Partnerships: Partnerships are expanding, highlighted by a collaboration with Sanofi and OpenAI to build AI software for drug development and increased business‑development capacity via Entrepreneurs in Residence. Engagements with large pharma partners, including Sanofi, underscore growing external validation and deal flow.

Product Line Growth: The pipeline is broadening through multiple in‑licenses—such as an anti‑CD226 program, a CNS‑penetrant TYK2 inhibitor, and a miR‑124 activator—and progression to first‑in‑human dosing of BLKR201 in 2026. Stated plans to reach 10–15 assets over 3–5 years align with recent portfolio expansion and clinical advancement.

Investor Backing & Capital Strength: Multiple funding rounds, including $8.2M in 2020, a $20M Series A in 2021 at a reported $100M valuation, and a $17M investment in 2026 from Enlightened Hospitality Investments, indicate strong capital support. The 2026 round is tied to product/engineering investment and go-to-market expansion.

Market Expansion: Customer reach spans hospitality, retail, transportation, healthcare, manufacturing, and logistics, with deployments cited across 32 countries and large-scale rollouts at brands such as McDonald’s and Elara Caring. A 2026 global partnership with Shake Shack and the addition of 700,000+ hospitality users in 2025 underscore geographic and vertical growth.

Strong Revenue Growth: ARR reportedly increased from $200K (Apr 2019) to $5M (Feb 2023), and U.S. growth of 159% was reported for fiscal 2023. These signals point to substantial revenue momentum even though more recent ARR figures are not disclosed.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strong Revenue Growth: Historical disclosures point to outsized growth (e.g., revenue increasing 5x in 2020 and more than tripling in 2021), and one dataset estimates revenue rose from $21M in 2023 to $31.9M in 2024. Together with an expanding customer base, this indicates continued commercial momentum.

Investor Backing & Capital Strength: Funding totals about $114.5M, including a $71M Series C backed by major firms, and the company attributes a new Boston office in 2023 to continued growth. This capital base and facilities expansion suggest ample resources to scale.

Market Expansion: The company reports serving 1,000+ companies and highlights new offices and international expansion, alongside recent senior hires in revenue and engineering to support scaling. These signals point to ongoing expansion in customers, footprint, and organizational capacity.

Investor Backing & Capital Strength: Capital capacity has expanded materially with a $525 million financing in July 2026, a $170 million securitization in December 2025, and an earlier credit facility increase to $450 million, bringing committed capacity near $700 million. Oversubscription of these offerings and repeated facility upsizing indicate strong institutional confidence and liquidity to scale originations.

Strategic Partnerships: A three-year, $1.8 billion forward-flow agreement with a private-credit fund provides a committed buyer for future advances. This arrangement broadens funding channels and supports higher, steadier origination throughput.

Product Line Growth: The company expanded beyond revenue-based financing to add business loans in select states. Current materials highlight offerings from $5,000 to $500,000, increasing addressable use cases.

Product Line Growth: Product offerings have expanded from consumer robots (gita, gitamini) to the B2B kilo platform, with additional features like Forward Following, Trips, and hybrid navigation introduced in 2025–2026. This points to an actively developing portfolio rather than a static lineup.

Market Expansion: The move from consumer-focused products into manufacturing, warehousing, and facilities management signals a broader addressable market. Parent-company materials in 2026 still describe active marketing and Boston-based manufacturing across multiple robot platforms.

Innovation-Driven Growth: Continued releases such as a production-ready hybrid-navigation AI model and other capability updates indicate ongoing R&D and technology maturation. Brand collaborations like the Grogu/Star Wars gitamini also reflect sustained commercialization activity.